Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade.

Aranda SS, Polack FP.

Front Immunol. 2019 May 7;10:1006. doi: 10.3389/fimmu.2019.01006. eCollection 2019. Review.

2.

The long road to protect infants against severe RSV lower respiratory tract illness.

Jares Baglivo S, Polack FP.

F1000Res. 2019 May 2;8. pii: F1000 Faculty Rev-610. doi: 10.12688/f1000research.18749.1. eCollection 2019. Review.

3.

Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.

Hijano DR, Vu LD, Kauvar LM, Tripp RA, Polack FP, Cormier SA.

Front Immunol. 2019 Mar 26;10:566. doi: 10.3389/fimmu.2019.00566. eCollection 2019. Review.

4.

Evaluation of nasal levels of interferon and clinical severity of influenza in children.

Comerlato Scotta M, Greff Machado D, Goecks Oliveira S, de Moura A, Rhoden Estorgato G, de Souza APD, Nery Porto B, de Araújo PD, Sarria EE, Pitrez PM, Jones MH, Araújo Pinto L, Tetelbom Stein R, Polack FP, Mattiello R.

J Clin Virol. 2019 May;114:37-42. doi: 10.1016/j.jcv.2019.02.003. Epub 2019 Mar 14.

PMID:
30913521
5.

The Syndrome We Agreed to Call Bronchiolitis.

Polack FP, Stein RT, Custovic A.

J Infect Dis. 2019 Jun 19;220(2):184-186. doi: 10.1093/infdis/jiz082.

6.

Toward Personalized Medicine in Bronchiolitis.

Paggi DA, Polack FP.

Am J Respir Crit Care Med. 2019 Jun 15;199(12):1456-1458. doi: 10.1164/rccm.201812-2371ED. No abstract available.

PMID:
30657699
7.

Mortality Associated With Acute Respiratory Infections Among Children at Home.

Caballero MT, Bianchi AM, Nuño A, Ferretti AJP, Polack LM, Remondino I, Rodriguez MG, Orizzonte L, Vallone F, Bergel E, Polack FP.

J Infect Dis. 2019 Jan 9;219(3):358-364. doi: 10.1093/infdis/jiy517.

8.

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

Mazur NI, Higgins D, Nunes MC, Melero JA, Langedijk AC, Horsley N, Buchholz UJ, Openshaw PJ, McLellan JS, Englund JA, Mejias A, Karron RA, Simões EA, Knezevic I, Ramilo O, Piedra PA, Chu HY, Falsey AR, Nair H, Kragten-Tabatabaie L, Greenough A, Baraldi E, Papadopoulos NG, Vekemans J, Polack FP, Powell M, Satav A, Walsh EE, Stein RT, Graham BS, Bont LJ; Respiratory Syncytial Virus Network (ReSViNET) Foundation.

Lancet Infect Dis. 2018 Oct;18(10):e295-e311. doi: 10.1016/S1473-3099(18)30292-5. Epub 2018 Jun 18. Review. Erratum in: Lancet Infect Dis. 2018 Jul 25;:.

9.

Interleukin-13 associates with life-threatening rhinovirus infections in infants and young children.

Caballero MT, Hijano DR, Acosta PL, Mateu CG, Marcone DN, Linder JE, Talarico LB, Elder JM, Echavarria M, Miller EK, Polack FP; INFANT Respiratory Network.

Pediatr Pulmonol. 2018 Jun;53(6):787-795. doi: 10.1002/ppul.23998. Epub 2018 Apr 17.

PMID:
29665312
10.

Crafting Live-Attenuated Vaccines Against Respiratory Syncytial Virus.

Polack FP.

J Infect Dis. 2018 Apr 11;217(9):1335-1337. doi: 10.1093/infdis/jiy038. No abstract available.

PMID:
29509928
11.

Respiratory syncytial virus is an "opportunistic" killer.

Caballero MT, Polack FP.

Pediatr Pulmonol. 2018 May;53(5):664-667. doi: 10.1002/ppul.23963. Epub 2018 Feb 20. Review.

12.

Respiratory Syncytial Virus During Pregnancy.

Polack FP.

Clin Infect Dis. 2018 May 17;66(11):1666-1667. doi: 10.1093/cid/cix1091. No abstract available.

13.

Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay.

Talarico LB, Byrne AB, Amarilla S, Lovera D, Vázquez C, Chamorro G, Acosta PL, Ferretti A, Caballero MT, Arbo A, Polack FP.

J Clin Virol. 2017 Dec;97:10-17. doi: 10.1016/j.jcv.2017.10.010. Epub 2017 Oct 18.

PMID:
29078078
14.

Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapy.

Soto AS, Fenoy IM, Sanchez VR, March F, Perrone Sibilia MD, Aldirico MLA, Picchio MS, Arcon N, Acosta PL, Polack FP, Martin V, Goldman A.

PLoS One. 2017 Oct 26;12(10):e0187002. doi: 10.1371/journal.pone.0187002. eCollection 2017.

15.

Age-associated differences in clinical manifestations and laboratory parameters during a dengue virus type 4 outbreak in Argentina.

Byrne AB, Gutierrez GF, Bruno A, Córdoba MT, Bono MM, Polack FP, Talarico LB, Quipildor MO.

J Med Virol. 2018 Feb;90(2):197-203. doi: 10.1002/jmv.24952. Epub 2017 Oct 20.

PMID:
28941278
16.

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.

Scheltema NM, Gentile A, Lucion F, Nokes DJ, Munywoki PK, Madhi SA, Groome MJ, Cohen C, Moyes J, Thorburn K, Thamthitiwat S, Oshitani H, Lupisan SP, Gordon A, Sánchez JF, O'Brien KL; PERCH Study Group, Gessner BD, Sutanto A, Mejias A, Ramilo O, Khuri-Bulos N, Halasa N, de-Paris F, Pires MR, Spaeder MC, Paes BA, Simões EAF, Leung TF, da Costa Oliveira MT, de Freitas Lázaro Emediato CC, Bassat Q, Butt W, Chi H, Aamir UB, Ali A, Lucero MG, Fasce RA, Lopez O, Rath BA, Polack FP, Papenburg J, Roglić S, Ito H, Goka EA, Grobbee DE, Nair H, Bont LJ.

Lancet Glob Health. 2017 Oct;5(10):e984-e991. doi: 10.1016/S2214-109X(17)30344-3. Erratum in: Lancet Glob Health. 2017 Dec;5(12 ):e1190.

17.

Viral bronchiolitis in young infants: new perspectives for management and treatment.

Caballero MT, Polack FP, Stein RT.

J Pediatr (Rio J). 2017 Nov - Dec;93 Suppl 1:75-83. doi: 10.1016/j.jped.2017.07.003. Epub 2017 Aug 30. Review.

18.

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.

Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, Alassani I, Ali A, Antonio M, Awasthi S, Awori JO, Azziz-Baumgartner E, Baggett HC, Baillie VL, Balmaseda A, Barahona A, Basnet S, Bassat Q, Basualdo W, Bigogo G, Bont L, Breiman RF, Brooks WA, Broor S, Bruce N, Bruden D, Buchy P, Campbell S, Carosone-Link P, Chadha M, Chipeta J, Chou M, Clara W, Cohen C, de Cuellar E, Dang DA, Dash-Yandag B, Deloria-Knoll M, Dherani M, Eap T, Ebruke BE, Echavarria M, de Freitas Lázaro Emediato CC, Fasce RA, Feikin DR, Feng L, Gentile A, Gordon A, Goswami D, Goyet S, Groome M, Halasa N, Hirve S, Homaira N, Howie SRC, Jara J, Jroundi I, Kartasasmita CB, Khuri-Bulos N, Kotloff KL, Krishnan A, Libster R, Lopez O, Lucero MG, Lucion F, Lupisan SP, Marcone DN, McCracken JP, Mejia M, Moisi JC, Montgomery JM, Moore DP, Moraleda C, Moyes J, Munywoki P, Mutyara K, Nicol MP, Nokes DJ, Nymadawa P, da Costa Oliveira MT, Oshitani H, Pandey N, Paranhos-Baccalà G, Phillips LN, Picot VS, Rahman M, Rakoto-Andrianarivelo M, Rasmussen ZA, Rath BA, Robinson A, Romero C, Russomando G, Salimi V, Sawatwong P, Scheltema N, Schweiger B, Scott JAG, Seidenberg P, Shen K, Singleton R, Sotomayor V, Strand TA, Sutanto A, Sylla M, Tapia MD, Thamthitiwat S, Thomas ED, Tokarz R, Turner C, Venter M, Waicharoen S, Wang J, Watthanaworawit W, Yoshida LM, Yu H, Zar HJ, Campbell H, Nair H; RSV Global Epidemiology Network.

Lancet. 2017 Sep 2;390(10098):946-958. doi: 10.1016/S0140-6736(17)30938-8. Epub 2017 Jul 7. Review.

19.

The Role of Heterotypic DENV-specific CD8+T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection.

Talarico LB, Batalle JP, Byrne AB, Brahamian JM, Ferretti A, García AG, Mauri A, Simonetto C, Hijano DR, Lawrence A, Acosta PL, Caballero MT, Paredes Rojas Y, Ibañez LI, Melendi GA, Rey FA, Damonte EB, Harris E, Polack FP.

EBioMedicine. 2017 Jun;20:202-216. doi: 10.1016/j.ebiom.2017.04.033. Epub 2017 Apr 27.

20.

Influenza and dengue virus co-infection impairs monocyte recruitment to the lung, increases dengue virus titers, and exacerbates pneumonia.

Schmid MA, González KN, Shah S, Peña J, Mack M, Talarico LB, Polack FP, Harris E.

Eur J Immunol. 2017 Mar;47(3):527-539. doi: 10.1002/eji.201646675. Epub 2017 Jan 12.

21.

Impact of a maternal immunization program against pertussis in a developing country.

Vizzotti C, Juarez MV, Bergel E, Romanin V, Califano G, Sagradini S, Rancaño C, Aquino A, Libster R, Polack FP, Manzur J.

Vaccine. 2016 Dec 7;34(50):6223-6228. doi: 10.1016/j.vaccine.2016.10.081. Epub 2016 Nov 12.

PMID:
27847175
22.

Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis.

Stein RT, Bont LJ, Zar H, Polack FP, Park C, Claxton A, Borok G, Butylkova Y, Wegzyn C.

Pediatr Pulmonol. 2017 Apr;52(4):556-569. doi: 10.1002/ppul.23570. Epub 2016 Oct 14. Review.

23.
24.

Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants.

High M, Cho HY, Marzec J, Wiltshire T, Verhein KC, Caballero MT, Acosta PL, Ciencewicki J, McCaw ZR, Kobzik L, Miller-DeGraff L, Gladwell W, Peden DB, Serra ME, Shi M, Weinberg C, Suzuki O, Wang X, Bell DA, Polack FP, Kleeberger SR.

EBioMedicine. 2016 Sep;11:73-84. doi: 10.1016/j.ebiom.2016.08.011. Epub 2016 Aug 6.

25.

The Impact of Respiratory Syncytial Virus Disease Prevention on Pediatric Asthma.

Caballero MT, Jones MH, Karron RA, Hartert TV, Simões EA, Stein RT, Wairagkar N, Polack FP; RSV & Pediatric Asthma Working Group.

Pediatr Infect Dis J. 2016 Jul;35(7):820-2. doi: 10.1097/INF.0000000000001167. No abstract available.

PMID:
27351360
26.

Mortality due to Respiratory Syncytial Virus. Burden and Risk Factors.

Geoghegan S, Erviti A, Caballero MT, Vallone F, Zanone SM, Losada JV, Bianchi A, Acosta PL, Talarico LB, Ferretti A, Grimaldi LA, Sancilio A, Dueñas K, Sastre G, Rodriguez A, Ferrero F, Barboza E, Gago GF, Nocito C, Flamenco E, Perez AR, Rebec B, Ferolla FM, Libster R, Karron RA, Bergel E, Polack FP.

Am J Respir Crit Care Med. 2017 Jan 1;195(1):96-103. doi: 10.1164/rccm.201603-0658OC.

PMID:
27331632
27.

Challenges in estimating RSV-associated mortality rates.

Zanone SM, Krause LK, Madhi SA, Bassat Q, Jha P, Simões EA, Wairagkar N, Polack FP; RSV and Child Mortality Working Group.

Lancet Respir Med. 2016 May;4(5):345-7. doi: 10.1016/S2213-2600(16)30042-X. Review. No abstract available.

PMID:
27304556
28.

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.

Acosta PL, Caballero MT, Polack FP.

Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95. doi: 10.1128/CVI.00609-15. Review.

29.

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.

Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Al Mamun A, Anovadiya AP, Araújo WN, Azziz-Baumgartner E, Báez C, Bantar C, Barhoush MM, Bassetti M, Beovic B, Bingisser R, Bonmarin I, Borja-Aburto VH, Cao B, Carratala J, Cuezzo MR, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Fraser J, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Higuera Iglesias AL, Hoeger PH, Hoffmann M, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Khandaker G, Knight M, Kusznierz G, Kuzman I, Kwan AM, Lahlou Amine I, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Manabe T, Mayo-Montero E, McGeer A, Memish ZA, Metan G, Mikić D, Mohn KG, Moradi A, Nymadawa P, Ozbay B, Ozkan M, Parekh D, Paul M, Poeppl W, Polack FP, Rath BA, Rodríguez AH, Siqueira MM, Skręt-Magierło J, Talarek E, Tang JW, Torres A, Törün SH, Tran D, Uyeki TM, van Zwol A, Vaudry W, Velyvyte D, Vidmar T, Zarogoulidis P; PRIDE Consortium Investigators, Nguyen-Van-Tam JS.

Influenza Other Respir Viruses. 2016 May;10(3):192-204. doi: 10.1111/irv.12363. Epub 2016 Feb 1.

30.

Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics.

Mazur NI, Martinón-Torres F, Baraldi E, Fauroux B, Greenough A, Heikkinen T, Manzoni P, Mejias A, Nair H, Papadopoulos NG, Polack FP, Ramilo O, Sharland M, Stein R, Madhi SA, Bont L; Respiratory Syncytial Virus Network (ReSViNET).

Lancet Respir Med. 2015 Nov;3(11):888-900. doi: 10.1016/S2213-2600(15)00255-6. Epub 2015 Sep 25. Review.

PMID:
26411809
31.

Alcohol during pregnancy worsens acute respiratory infections in children.

Libster R, Ferolla FM, Hijano DR, Acosta PL, Erviti A, Polack FP; INFANT Respiratory Network.

Acta Paediatr. 2015 Nov;104(11):e494-9. doi: 10.1111/apa.13148.

PMID:
26249835
32.

The changing landscape of respiratory syncytial virus.

Polack FP.

Vaccine. 2015 Nov 25;33(47):6473-8. doi: 10.1016/j.vaccine.2015.06.119. Epub 2015 Aug 4. Review.

33.

Childhood pneumonia: the role of viruses.

Zar HJ, Polack FP.

Thorax. 2015 Sep;70(9):811-2. doi: 10.1136/thoraxjnl-2015-207320. Epub 2015 Jun 19. No abstract available.

PMID:
26092921
34.

Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).

Larkin EK, Gebretsadik T, Moore ML, Anderson LJ, Dupont WD, Chappell JD, Minton PA, Peebles RS Jr, Moore PE, Valet RS, Arnold DH, Rosas-Salazar C, Das SR, Polack FP, Hartert TV; INSPIRE Study.

BMC Pulm Med. 2015 Apr 30;15:45. doi: 10.1186/s12890-015-0040-0.

35.

TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization.

Caballero MT, Serra ME, Acosta PL, Marzec J, Gibbons L, Salim M, Rodriguez A, Reynaldi A, Garcia A, Bado D, Buchholz UJ, Hijano DR, Coviello S, Newcomb D, Bellabarba M, Ferolla FM, Libster R, Berenstein A, Siniawaski S, Blumetti V, Echavarria M, Pinto L, Lawrence A, Ossorio MF, Grosman A, Mateu CG, Bayle C, Dericco A, Pellegrini M, Igarza I, Repetto HA, Grimaldi LA, Gudapati P, Polack NR, Althabe F, Shi M, Ferrero F, Bergel E, Stein RT, Peebles RS, Boothby M, Kleeberger SR, Polack FP.

J Clin Invest. 2015 Feb;125(2):571-82. doi: 10.1172/JCI75183. Epub 2015 Jan 2.

36.

Protective phenotypes of club cells and alveolar macrophages are favored as part of endotoxin-mediated prevention of asthma.

García LN, Leimgruber C, Uribe Echevarría EM, Acosta PL, Brahamian JM, Polack FP, Miró MS, Quintar AA, Sotomayor CE, Maldonado CA.

Exp Biol Med (Maywood). 2015 Jul;240(7):904-16. doi: 10.1177/1535370214562338. Epub 2014 Dec 11.

37.

Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4.

Coviello S, Wimmenauer V, Polack FP, Irusta PM.

Hum Vaccin Immunother. 2014;10(10):2896-902. doi: 10.4161/hv.29784. Epub 2014 Nov 19.

38.

Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction.

Scotta MC, Veras TN, Klein PC, Tronco V, Polack FP, Mattiello R, Pitrez PM, Jones MH, Stein RT, Pinto LA.

Vaccine. 2014 Jul 31;32(35):4495-9. doi: 10.1016/j.vaccine.2014.06.042. Epub 2014 Jun 21.

PMID:
24958703
39.

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Báez C, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Iglesias AL, Hoger PH, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Knight M, Kudo K, Kusznierz G, Kuzman I, Kwan AM, Amine IL, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Mayo-Montero E, McGeer A, Memish Z, Metan G, Mickiene A, Mikić D, Mohn KG, Moradi A, Nymadawa P, Oliva ME, Ozkan M, Parekh D, Paul M, Polack FP, Rath BA, Rodríguez AH, Sarrouf EB, Seale AC, Sertogullarindan B, Siqueira MM, Skręt-Magierło J, Stephan F, Talarek E, Tang JW, To KK, Torres A, Törün SH, Tran D, Uyeki TM, Van Zwol A, Vaudry W, Vidmar T, Yokota RT, Zarogoulidis P; PRIDE Consortium Investigators, Nguyen-Van-Tam JS.

Lancet Respir Med. 2014 May;2(5):395-404. doi: 10.1016/S2213-2600(14)70041-4. Epub 2014 Mar 19. Review.

40.

A genetic model of differential susceptibility to human respiratory syncytial virus (RSV) infection.

Ciencewicki JM, Wang X, Marzec J, Serra ME, Bell DA, Polack FP, Kleeberger SR.

FASEB J. 2014 Apr;28(4):1947-56. doi: 10.1096/fj.13-239855. Epub 2014 Jan 13.

41.

The Argentina Premature Asthma and Respiratory Team (APART): objectives, design, and recruitment results of a prospective cohort study of viruses and wheezing in very low birth weight infants.

Plachco T, Libster R, Linder JE, Bossi L, Aspres N, Bauer G, Williams JV, Polack FP, Miller EK.

Adv Pediatr Res. 2014;1. pii: 7. doi: 10.12715/apr.2014.1.7. Epub 2014 Dec 31.

42.

T helper type 2 bias and type 17 suppression in primary dengue virus infection in infants and young children.

Talarico LB, Bugna J, Wimmenauer V, Espinoza MA, Quipildor MO, Hijano DR, Beccaria M, Wurster V, Cavagnaro LE, Martinez D, Fattore G, Batalle JP, Acosta PL, Reynoso N, Melendi GA, Rey FA, Libster R, Polack FP.

Trans R Soc Trop Med Hyg. 2013 Jul;107(7):411-9. doi: 10.1093/trstmh/trt044. Epub 2013 Jun 13.

PMID:
23764739
43.

Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children.

Ferolla FM, Hijano DR, Acosta PL, Rodríguez A, Dueñas K, Sancilio A, Barboza E, Caría A, Gago GF, Almeida RE, Castro L, Pozzolo C, Martínez MV, Grimaldi LA, Rebec B, Calvo M, Henrichsen J, Nocito C, González M, Barbero G, Losada JV, Caballero MT, Zurankovas V, Raggio M, Schavlovsky G, Kobylarz A, Wimmenauer V, Bugna J, Williams JV, Sastre G, Flamenco E, Pérez AR, Ferrero F, Libster R, Grijalva CG, Polack FP.

Am J Respir Crit Care Med. 2013 May 1;187(9):983-90. doi: 10.1164/rccm.201301-0016OC.

PMID:
23449690
44.

Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.

Polack FP, Lydy SL, Lee SH, Rota PA, Bellini WJ, Adams RJ, Robinson HL, Griffin DE.

Clin Vaccine Immunol. 2013 Feb;20(2):205-10. doi: 10.1128/CVI.00394-12. Epub 2012 Dec 12.

45.

Human rhinoviruses in severe respiratory disease in very low birth weight infants.

Miller EK, Bugna J, Libster R, Shepherd BE, Scalzo PM, Acosta PL, Hijano D, Reynoso N, Batalle JP, Coviello S, Klein MI, Bauer G, Benitez A, Kleeberger SR, Polack FP.

Pediatrics. 2012 Jan;129(1):e60-7. doi: 10.1542/peds.2011-0583. Epub 2011 Dec 26.

46.

A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses.

Miller EK, Hernandez JZ, Wimmenauer V, Shepherd BE, Hijano D, Libster R, Serra ME, Bhat N, Batalle JP, Mohamed Y, Reynaldi A, Rodriguez A, Otello M, Pisapia N, Bugna J, Bellabarba M, Kraft D, Coviello S, Ferolla FM, Chen A, London SJ, Siberry GK, Williams JV, Polack FP.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):508-16. doi: 10.1164/rccm.201108-1462OC. Epub 2011 Dec 1.

47.

Pediatric hospitalizations due to influenza in 2010 in Argentina.

Libster R, Coviello S, Cavalieri ML, Morosi A, Alabart N, Alvarez L, Ferrero F, Edwards KM, Polack FP.

N Engl J Med. 2010 Dec 16;363(25):2472-3. doi: 10.1056/NEJMc1008806. No abstract available.

48.

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.

Monsalvo AC, Batalle JP, Lopez MF, Krause JC, Klemenc J, Hernandez JZ, Maskin B, Bugna J, Rubinstein C, Aguilar L, Dalurzo L, Libster R, Savy V, Baumeister E, Aguilar L, Cabral G, Font J, Solari L, Weller KP, Johnson J, Echavarria M, Edwards KM, Chappell JD, Crowe JE Jr, Williams JV, Melendi GA, Polack FP.

Nat Med. 2011 Feb;17(2):195-9. doi: 10.1038/nm.2262. Epub 2010 Dec 5.

49.

Fever and bleeding in a newborn baby.

Bugna J, Moreno J, Sanchez S, Sanchez I, Polack FP.

Pediatr Infect Dis J. 2010 Dec;29(12):1153-8. doi: 10.1097/INF.0b013e3181e50e24. No abstract available.

PMID:
21099655
50.

Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses.

Melendi GA, Bridget D, Monsalvo AC, Laham FF, Acosta P, Delgado MF, Polack FP, Irusta PM.

Virus Genes. 2011 Feb;42(1):46-54. doi: 10.1007/s11262-010-0545-9. Epub 2010 Nov 4.

Supplemental Content

Loading ...
Support Center